Valuation Alkem Laboratories Limited

Stocks

Market Closed - NSE India S.E. 15:05:06 13/10/2026 +04			5-day change	1st Jan Change
5,250.00 ^INR	+0.86%		-0.79%	-4.66%

09-24	Alkem Laboratories Limited Announces Resignation of Nitin Agrawal as Chief Financial Officer	CI
09-24	Alkem Laboratories Limited Announces Resignation of Nitin Agrawal as Key Managerial Personnel and Senior Management Personnel, Effective September 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	432,909	406,055	590,890	583,680	633,575	627,716	-	-
Change	-	-6.2%	45.52%	-1.22%	8.55%	-0.92%	-	-
Enterprise Value (EV) ¹	433,805	393,853	587,236	578,678	632,481	614,592	599,531	590,335
Change	-	-9.21%	49.1%	-1.46%	9.3%	-2.83%	-2.45%	-1.53%
P/E	26.3x	41.3x	32.9x	27x	27.5x	27.3x	23.8x	20.5x
PBR	5.01x	4.49x	5.73x	4.87x	4.58x	4.08x	3.58x	3.16x
PEG	-	-1x	0.4x	1.3x	4.37x	-97.38x	1.6x	1.3x
Capitalization / Revenue	4.07x	3.5x	4.66x	4.5x	4.31x	3.76x	3.37x	3.07x
EV / Revenue	4.08x	3.4x	4.64x	4.46x	4.3x	3.68x	3.22x	2.88x
EV / EBITDA	21.1x	24.5x	26.2x	23x	21x	18x	15.2x	13.3x
EV / EBIT	24.8x	30.3x	30.2x	26.9x	24.1x	20.7x	17.6x	15.1x
EV / FCF	55.4x	27.1x	33.3x	45.3x	42.8x	59.6x	29.4x	23.1x
FCF Yield	1.81%	3.69%	3%	2.21%	2.33%	1.68%	3.41%	4.32%
Dividend per Share ²	34	25	40	45	53	50.29	55.4	63.85
Rate of return	0.94%	0.74%	0.81%	0.92%	1%	0.96%	1.06%	1.22%
EPS ²	137.6	82.31	150.2	181.1	192.5	192	221	256.1
Distribution rate	24.7%	30.4%	26.6%	24.8%	27.5%	26.2%	25.1%	24.9%
Net sales ¹	106,342	115,993	126,676	129,645	147,123	166,949	186,008	204,727
EBITDA ¹	20,529	16,094	22,455	25,122	30,052	34,204	39,337	44,427
EBIT ¹	17,490	12,990	19,462	21,550	26,232	29,661	34,151	39,180
Net income ¹	16,456	9,842	17,958	21,655	23,018	23,147	27,276	31,030
Net Debt ¹	896.1	-12,202	-3,654	-5,003	-1,094	-13,125	-28,185	-37,381
Reference price ²	3,620.70	3,396.10	4,942.00	4,881.70	5,299.00	5,250.00	5,250.00	5,250.00
Nbr of stocks (in thousands)	119,565	119,565	119,565	119,565	119,565	119,565	-	-
Announcement Date	13/05/22	19/05/23	29/05/24	29/05/25	28/05/26	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ALKEM LABORATORIES LIMITED	27.15x	3.65x	17.82x	0.97%	6.51B
ELI LILLY AND COMPANY	33.65x	12.2x	25.64x	0.58%	1,054B
JOHNSON & JOHNSON	29.26x	6.48x	18.46x	2.02%	636B
ABBVIE INC.	35.78x	8.25x	17.01x	2.47%	497B
MERCK & CO., INC.	111.13x	5.93x	25.32x	2.35%	359B
ROCHE HOLDING AG	19.43x	4.75x	11.8x	2.78%	345B
NOVARTIS AG	20.12x	5.29x	13.01x	3.01%	273B
ASTRAZENECA PLC	20.57x	4.22x	12.08x	2.1%	246B
AMGEN INC.	26.51x	6.86x	12.28x	2.42%	226B
GILEAD SCIENCES, INC.	-45.64x	6.72x	26.17x	2.19%	187B
Average	27.80x	6.43x	17.96x	2.09%	382.87B
Weighted average by Cap.	33.08x	7.87x	19.50x	1.89%